IBD NORTHERN LTS FD TR IV

Ownership history in WorthPointe, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which WorthPointe, LLC reported a position in NORTHERN LTS FD TR IV (IBD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.99% (2025 Q4)
Avg. % of fund
1.29%
First filed
2023 Q3
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 312,296 +202,160 +183.6% 1.99% $7.6M $24.06
2023 Q4 ADDED 110,136 +69,041 +168.0% 1.32% $2.6M $21.57
2023 Q3 INITIATED 41,095 0.55% $930K
% of Fund (quarterly)    IBD price (monthly, adj. close)
← Back to WorthPointe, LLC Holdings